HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Trial of amitriptyline versus flunarizine as treatment of vestibular diseases. A preliminary study].

Abstract
109 patients with vestibular disease were included in two different treatments with amitriptyline (Group A:53 patients with depressive symptoms), or flunarizine (Group B: 56 patients). Vertiginous symptoms, basic vestibular exploration, depressive disorder, cochlear symptoms, vegetative disorders and headache were evaluated. Among the patients treated with amitriptyline a significant decrease in the vertiginous symptoms were observed. The possible mechanism of action were analyzed too.
AuthorsJ L Pardal Refoyo, L D Beltrán Mateos
JournalActa otorrinolaringologica espanola (Acta Otorrinolaringol Esp) 1991 Nov-Dec Vol. 42 Issue 6 Pg. 433-7 ISSN: 0001-6519 [Print] Spain
Vernacular TitleEnsayo de amitriptilina versus flunarizina como tratamiento en patología vestibular. Estudio preliminar.
PMID1790064 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Amitriptyline
  • Flunarizine
Topics
  • Amitriptyline (administration & dosage, adverse effects, therapeutic use)
  • Depression (drug therapy)
  • Female
  • Flunarizine (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Time Factors
  • Vertigo (drug therapy)
  • Vestibular Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: